Call us today for help! (214) 295-5011
To bring greater awareness to lung cancer and its treatment, the American Lung Association has rolled out its State of Lung Cancer 2023 Report. The findings provide hope – treatment options are improving and survival rates have dramatically increased, but the report also showcases what steps can be taken to save even more lives. About …
Lung cancer is a significant public health concern. In the United States alone, it is estimated that approximately 14.2 million individuals fall into the high-risk category for lung cancer and are eligible for screening. Early detection of lung cancer greatly increases the chances of successful treatment and improved outcomes. An initiative aimed at raising awareness about …
Lung cancer vaccines may sound like science fiction, but a Cuban developed immunotherapy already exists and is undergoing clinical trials in the United States. Several other potential lung cancer vaccines are currently being studied. Vaccines may become a standard treatment option for lung cancer in the not too distant future. What Would a Lung …
Scientists at Peking University People’s Hospital in China announced a rapid blood test for early-stage lung cancer. Named Lung Cancer Artificial Intelligence Detector (LCAID), it is non-invasive and evaluates levels of lipid biomarkers in plasma samples. This rapid blood test has a low false-positive rate, may detect lung cancer as rapidly as 90 minutes, and can test 24 blood …
Some immunocompromising medical conditions were approved by the Food and Drug Administration (FDA) on August 12th to receive third dose booster shots. This is an amendment to the emergency use authorization (EUA) for the Pfizer and Moderna vaccines. Acting FDA Commissioner Dr. Janet Woodcock said, “Today’s action allows doctors to boost immunity in certain immunocompromised …
